China

George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

George Clinical in China

Tweet about this on TwitterShare on FacebookShare on LinkedIn

China is George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

With its immense potential for patient recruitment and a rapidly growing pharmaceutical market, China, currently the third largest in the world, is an obvious choice for many when entering the Asian market.

The Chinese healthcare delivery system consists of public hospitals and community healthcare centers, with an increasing private care system. Only GCP accredited sites are eligible for running commercial Phase I, II and III studies, and this accreditation can only be achieved by public hospitals in China. The accreditation is issued by the CFDA and NHPFC based upon a site inspection. Accreditation is renewed every 3 years, with a quality review performed by the PFDA every year.

George Clinical has an extensive network of over 260 trial centers in 50 cities for Phase II-IV trials, and a wider network that includes community health centers in semi-urban and rural areas for Phase IV trials.

What are the benefits of conducting clinical trials in China?

  • China has access to a large patient pool
  • Rapidly developing medical infrastructure in urban centres and centres of excellence for many common diseases such as hypertension, diabetes and renal disease
  • Low operational costs

What are the prevalent diseases in China?

  1. Stroke
  2. Ischaemic Heart Disease
  3. Chronic obstructive pulmonary disease
  4. Cancer
  5. Road injury
  6. Hypertension
  7. Diabetes mellitus
  8. Lower respiratory infections

George Clinical China News

2018医疗大数据分析研讨会在京召开

1月2日,乔治健康研究所举办了医疗大数据分析研讨会,希望通过各领域大数据应用的经验分享,整合现有数据资源,开启健康医疗新型合作与发展的模式,产出可操作性的医疗大数据课题。来自公共卫生、流行病学、生物医学工程以及临床医疗的多位专家学者参与了此次会议。

Big data analysis in healthcare workshop accomplished in Beijing

As a kick start to the new calendar year, The George Institute, China held a ‘big data analysis in healthcare workshop’ on 2 January 2018.  The aim was to facilitate new ideas and modes of cooperation and development in healthcare arena through open dialogue and...

2018年新年快乐

又到了这辞旧迎新的时刻,在2018年到来之际,乔治健康研究所借此机会向所有的合作伙伴表示最诚挚的谢意,感谢你们一直以来的信任和支持。

2018 Happy New Year

As the year 2017 is coming to an end and we will soon embrace the year of Dog, The George Institute, China would like to take this opportunity to express our sincere appreciation for your continued trust and steady support for our research work.

中澳代表团共同寻求健康与医学研究合作机会

12月7日, 由澳大利亚新州卫生部长兼医学研究部长The Hon. Brad Hazzard MP议员阁下带领的医疗健康研究代表团访问了乔治健康研究所。新州卫生部常务副部长 Elizabeth Koff 和澳大利亚爵级员佐勋章获得者、澳中特使 Jim Harrowell AM 博士也出席了此次会谈。

The Australian state of New South Wales (NSW) and China explore opportunities to grow in health and medical research

NSW Minister for Health and Medical Research, The Honourable Brad Hazzard MP, visited The George Institute, China on 7 December with a health and medical delegation led by the Minister in China as part of the NSW-Guangdong Joint Economic Meeting (JEM) on 5 Decem...

Contact

George Clinical Address:
Level 18, Tower B, Horizon Tower
Haidian District
Beijing, 100088
P.R. China

2223, 22/F Tomson Commercial Building,
710 Dongfang Road, Pudong District
Shanghai, 200122
P.R. China

Details

Number of Personnel: 50
In-country Services:

Beijing
Project Management, Clinical Operations, Data Management, Medical and Safety Services, Clinical Compliance, Regulatory Services, Statistics, Health Economics

Shanghai
Clinical Operations

Chengdu
Clinical Operations

Harbin
Project Management, Clinical Operations

Population: 1.4 billion
Official Language: Putonghua (Mandarin). Local dialects may be used
Hospital Records Language: Simplified Chinese
Electronic Hospital Records: Currently, paper records are used.

Twitter Facebook LinkedIn